Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost SR vs SLT in Glaucoma/OHT
NCT02636946Phase 3Completed
- Sponsor
- Allergan
- Start
- Feb 2016
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 3 trial of bimatoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Allergan. Started Feb 2016; status: completed.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02636946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636946.